LABORATORY CORP OF AMERICA HOLDINGS is 4.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($22.17 B vs $4.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CAI | LH |
|---|---|---|
| Market cap | $4.85 B | $22.17 B |
| US-listed rank | #1404 | #583 |
| Revenue (latest FY) | $812.03M | $13.95B |
| Net income (latest FY) | -$68.09M | $877.00M |
| Net margin | -8.4% | 6.3% |
| P/E (trailing FY) | - | 25.3 |
| SEC filings | 102 | 3,857 |
LABORATORY CORP OF AMERICA HOLDINGS is 4.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($22.17 B vs $4.85 B).
In their latest fiscal years, Caris Life Sciences, Inc. reported $812.03M in revenue while LABORATORY CORP OF AMERICA HOLDINGS reported $13.95B.
Full pages: Caris Life Sciences, Inc. and LABORATORY CORP OF AMERICA HOLDINGS, or browse the full rankings.